Pancuronium Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 12, 2023.
Applies to pancuronium: parenteral injection.
Warning
- Should be administered only by adequately trained clinicians experienced in the use and complications of neuromuscular blocking agents.100
Side effects include:
Various degrees of skeletal muscle weakness.
For Healthcare Professionals
Applies to pancuronium: intravenous solution.
Hypersensitivity
Uncommon (0.1% to 1%): Severe anaphylactic reactions[Ref]
Local
Uncommon (0.1% to 1%): Pain and burning at injection site[Ref]
Musculoskeletal
Frequency not reported: Prolonged paralysis, disuse atrophy, and areflexia have been reported with prolonged use of this drug[Ref]
Ocular
Frequency not reported: Decreased intraocular pressure, miosis[Ref]
Respiratory
Rare (less than 0.1%): Bronchospasm, wheezing
Frequency not reported: Apnea, respiratory depression[Ref]
Cardiovascular
Very common (10% or more): Mild to moderate increase in blood pressure and/or pulse rate (10%)
Rare (less than 0.1%): Hypotension, cardiovascular collapse, flushing, edema, arrhythmia, bradycardia
Frequency not reported: Dysrhythmias, increased cardiac output[Ref]
Dermatologic
Uncommon (0.1% to 1%): Transient rash, pruritus, redness[Ref]
Gastrointestinal
Frequency not reported: Hypersalivation[Ref]
Frequently asked questions
More about pancuronium
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: neuromuscular blocking agents
- Breastfeeding
Patient resources
Professional resources
References
1. Cerner Multum, Inc. UK Summary of Product Characteristics.
2. Cerner Multum, Inc. Australian Product Information.
3. Product Information. Pancuronium Bromide (pancuronium). Hospira Inc. 2018.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
